Status:
COMPLETED
Albumin, Total and Free Fraction of Mycophenolic Acid, and Measurement of IMPDH Activity in Liver Transplants.
Lead Sponsor:
Oslo University Hospital
Conditions:
Liver Transplant
Eligibility:
All Genders
18+ years
Brief Summary
In this study we aim to investigate to what extent the serum albumin concentration in liver transplant patients treated with mycophenolic acid (MPA) affect the free fraction of MPA. Furthermore we wil...
Detailed Description
This is a prospective, open, non randomised study without intervention. Our main goal is to find out what effect the albumin concentration has on the free fraction MPA and IMPDH activity in the lympho...
Eligibility Criteria
Inclusion
- Liver transplant, MPA treatment
Exclusion
- malignant disease
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00995956
Start Date
January 1 2010
End Date
September 1 2010
Last Update
September 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo university Hospital, Rikshospitalet
Oslo, Oslo County, Norway, 0027